Article
Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society - 1 Mar 2017
Altes Talissa A, Johnson Mac, Fidler Meredith, Botfield Martyn, Tustison Nicholas J, Leiva-Salinas Carlos, de Lange Eduard E, Froh Deborah, Mugler John P
Abstract excerpt
BACKGROUND: This pilot study evaluated the effect of short- and long-term ivacaftor treatment on hyperpolarized 3He-magnetic resonance imaging (MRI)-defined ventilation defects in patients with cystic fibrosis aged ≥12years with a G551D-CFTR mutation. METHODS: Part A (single-blind) comprised 4weeks of ivacaftor treatment; Part B (open-label) comprised 48weeks of treatment. The primary outcome was change from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
